US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
オーストラリア
ASX
Prescient Therapeutics Limited (PTX) 銘柄情報

Prescient Therapeutics Limited (PTX)

0.071

-0.001

( -1.39% )

更新日時： 08:59:04

Prescient Therapeutics Limited (PTX) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

0.071

( -1.39% )

買値

0.071

売値

0.072

出来高

72,667

0.071 日の範囲 0.071

0.04 52 週間の範囲 0.125

時価総額

前日終値

0.072

始値

0.071

時刻

最終取引時間

09:03:59

財務取引量

-

VWAP

-

平均取引量 (3 か月)

AUD 932,421

発行済株式数

1,051,514,543

配当利回り

PER

-7.9

1 株当たり利益 (EPS)

-0.01

歳入

4.27M

純利益

-8.86M

Prescient Therapeutics Limited, a clinical stage oncology company, develops drugs for the treatment of haematological and solid cancers in Australia. Its lead drug candidate is PTX-100, a first in class targeted therapy which can disrupt the RAS family pathway by inhibiting the prenylation action of... Prescient Therapeutics Limited, a clinical stage oncology company, develops drugs for the treatment of haematological and solid cancers in Australia. Its lead drug candidate is PTX-100, a first in class targeted therapy which can disrupt the RAS family pathway by inhibiting the prenylation action of the enzyme GGT-1. The company was formerly known as Virax Holdings Limited and changed its name to Prescient Therapeutics Limited in December 2014. Prescient Therapeutics Limited was incorporated in 1986 and is based in Melbourne, Australia. 詳細を表示

セクター

Healthcare

業界

Biotechnology & Life Sciences

ウェブサイト

ptxtherapeutics.com

本社

Melbourne, Australia

設立

1986

Prescient Therapeutics Limited is listed in the Healthcare sector of the オーストラリア証券取引所 with ticker PTX. The last closing price for Prescient Therapeutics was AUD0.07. Over the last year, Prescient Therapeutics shares have traded in a share price range of AUD 0.04 to AUD 0.125.

Prescient Therapeutics currently has 1,051,514,543 shares in issue. The market capitalisation of Prescient Therapeutics is AUD74.66 million. Prescient Therapeutics has a price to earnings ratio (PE ratio) of -7.90.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.007	-8.97435897436	0.078	0.081	0.071	942640	0.0766299	DE
4	0.018	33.9622641509	0.053	0.088	0.051	1138883	0.07126903	DE
12	0.013	22.4137931034	0.058	0.088	0.049	892366	0.06152568	DE
26	-0.009	-11.25	0.08	0.125	0.049	1427378	0.07557647	DE
52	0.024	51.0638297872	0.047	0.125	0.04	1373266	0.06324709	DE
156	-0.013	-15.4761904762	0.084	0.125	0.037	953593	0.05894324	DE
260	-0.059	-45.3846153846	0.13	0.305	0.037	1314534	0.13339556	DE

PTX - Frequently Asked Questions (FAQ)

What is the current Prescient Therapeutics Limited share price?

The current share price of Prescient Therapeutics Limited is AUD 0.071

How many Prescient Therapeutics Limited shares are in issue?

Prescient Therapeutics Limited has 1,051,514,543 shares in issue

What is the market cap of Prescient Therapeutics Limited?

The market capitalisation of Prescient Therapeutics Limited is AUD 74.66M

What is the 1 year trading range for Prescient Therapeutics Limited share price?

Prescient Therapeutics Limited has traded in the range of AUD 0.04 to AUD 0.125 during the past year

What is the PE ratio of Prescient Therapeutics Limited?

The price to earnings ratio of Prescient Therapeutics Limited is -7.9

What is the cash to sales ratio of Prescient Therapeutics Limited?

The cash to sales ratio of Prescient Therapeutics Limited is 19.23

What is the registered address of Prescient Therapeutics Limited?

The registered address for Prescient Therapeutics Limited is Suite 2, Melbourne, Victoria, 3000

What is the Prescient Therapeutics Limited website address?

The website address for Prescient Therapeutics Limited is ptxtherapeutics.com

Which industry sector does Prescient Therapeutics Limited operate in?

Prescient Therapeutics Limited operates in the Biotechnology & Life Sciences sector

JALEB

I guess my posts are getting deleted…but here it goes again:
You’re presenting speculation as fact again. An employment contract expiring is not evidence that someone was “pushed out.”
In fact, Castellum’s own SEC filing stated there was no dispute with Jay Wright upon his resignation.

Investor082

Investor082 1分前

LOL, LP is likely to change her mind in 2027 saying they have a new concept for an even smaller design. So until this is formally certified, no one cares. And that ain’t happening for a couple of years at the very least. It’s more likely that LP abandons Flaskworks/Eden completely than a certificati

jesster64

jesster64 1分前

Take the wife and kids out for lobster and tell them while sipping a big glass of whiskey. Then go home and bask all night in the glow of being able to say "I told you so".

Tstorm

I agree this is HUGE - $LBRG

Preciouslife1

Preciouslife1 2分前

https://thecryptobasic.com/xrp-not-ready-for-expansion-yet-analyst-expects-more-range-bound-trading-as-price-slips-to-1-19/ PRINTING AT $1.18 NOW :(

sentiment_stocks

sentiment_stocks 3分前

The New GBM Definition (WHO 2021 IDH-wildtype Data): 12.3 months (Standard of Care)

I wonder what the survival rate is without SOC? Didn't Stupp get just an additional few months?

US Market News

US Market News 3分前

Ford Bronco Filson: Specs, Features, and Everything You Need to KnowJune 3, 2026 9:00 PM
Business Wire Originally published on

US Market News

US Market News 3分前

B&G Foods Announces Pricing of Offering of Senior Notes due 2031June 3, 2026 9:12 PM
Business Wire B&G Foods, Inc. (NYSE: BGS) announced today the pricing of an offering of $475.0 million aggregate principal amount of 11.00% senior notes due 2031 in a transaction exempt from re

creakyhottie

creakyhottie 4分前

Diamondguru-one Question: the way I read it they are selling 100 million Preferred at $1 a share, to bring in $100 million.

So it seems to me that the $110 million in transactions they keep hinting at, may not be the sale of mining interests (as for that they do not need to sell P

JRyan

Somber opening, but they honored John Brown well. Good tribute.

Otherwise a very upbeat meeting, great news with the condensate, I had brought up that possibility in previous articles.

The concern about the Texas listing is a legit one.

Anyhow enjoy!

THEBEASTMUGABI

THEBEASTMUGABI 5分前

No ! I wish I would have sold some at 72 though.

jesster64

jesster64 5分前

"I strongly suspect that approval does depend on the construction of the C suite and the upgrading of its electrical infrastructure to a point where the MHRA is assured that the completion of that buildout is imminent.'
You know what would help with that? APPROVAL !! Then they would have reve

MrMontag

MrMontag 6分前

I wonder how dependent the capex figure is for the traxys deal. I wonder how many "chunks" of the dfs can be sent to exim without an accurate capex figure. If we dont hear anything about it I hope it is considered non material info and the have it and use it without saying anything.

Shrinky Dynk

Shrinky Dynk 6分前

the time stamp possibly 10/7 .02

cadillacdave

cadillacdave 7分前

Beast are you shorting this again, pulling it down for a better entry point? 😱

I guess we can say you are a force of one.

jour_trader

jour_trader 8分前

You might be as honest as a politician. Show me where I said it would crater overnight. You keep making garbage up.
I give it about 3-4 months and the pricing will be in a quick tailspin and will soon after bottom out.
First competitor takes about 20% discount. Once 4th competitor en

HGiLS

I read you I read how you predicted our profitability would go down and how it actually grew. You are boring. Must smell where you are Be careful where you walk. PP

1jas

splintered sunlight

splintered sunlight 11分前

What the hell does this even mean?

I know it's not good for shareholders, that's for sure........

Hey_Its_That_Guy

Hey_Its_That_Guy 11分前

What the hell happened to that bill that was gonna be released in the coming weeks?

Elon Muskrat

Elon Muskrat 12分前

Looking like a beast in the making, will add more tomorrow

HGiLS

Heard you how 27 billion will disappear overnight.

Dooms day coming.

Got news for you day trader. We are moving up.

BTuna

Re: agreed Gilead. Hilarious screenshot, is that yours? Ps, I sent you a PM about the beta tester request!

WolfOfGrnStreet

WolfOfGrnStreet 13分前

Just remember, you never know who will flip the switch! GLTA!!!

Prescient Therapeutics

China Shenhua Energy

Invesco European Househo...

Bahl and Gaynor Small Mi...

Daiichi Sankyo (PK)

Careview Communications (QB)

Franklin Templeton ICAV ...

Nektar Therapeutics

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。